ABSTRACT. Glycerol 3-phosphate is an initial metabolite in the biosynthesis of phosphoglycerides and triacylglycer01s. Both glycerol and glucose are precursors of glycerol 3-phosphate. Cultured skin fibroblasts from patients with glycerol kinase deficiency utilized glucose, but not glycerol in the biosynthesis of phosphoglycerides and triacylglycer01s. Phosphoglyceride and triacylglycerol biosynthesis in glycerol kinase deficiency fibroblasts is not diminished by the inability to use glycerol as a precursor of glycerol 3-phosphate. (Pediatr Res 19: 313-314, 1985) Abbreviation GKD, glycerol kinase deficiency Glycerol 3-phosphate is an important intermediate in phosphoglyceride and triacylglycerol biosynthesis. It is derived from glycerol and ATP by the activity of glycerol kinase (adenosine triphosphate: glycerol 3-phosphotransferase, EC 2.7.1.30), or from dihydroxyacetone phosphate and NADH + H+ by the activity of glycerol 3-phosphate dehydrogenase (glycerol 3-phosphate: NAD+ 2-oxidoreductase, EC 1.1.1.94) (7) . We and others have described several patients who have GKD. GKD is an X-linked disorder that has been identified in adults, juveniles, and infants. Adults with GKD have pseudohypertriglyceridemia secondary to hyperglycerolemia (4, 8, 11) . They have no apparent clinical problems. Two juveniles with GKD began to have symptoms at 4 yr of age of episodic vomiting, acidemia and stupor (2, 3). Infants with GKD have hyperglycerolemia, glyceroluria, adrenal hypoplasia, psychomotor retardation, nonspecific myopathy, and X-linked inheritance (1, 5, 9) . Guggenheim et al. (5) suggested the clinical phenotype in infantile GKD patients could be due to glycerol excess or glycerol 3-phosphate deficiency, or both. However, no one has identified the cause of the diverse clinical problems associated with infantile GKD.
Since GKD blocks one of the pathways for generating glycerol 3-phosphate, we studied phosphoglyceride and triacylglycerol biosynthesis in cultured fibroblasts from five children with infantile GKD.
MATERIALS AND METHODS
Biosynthesis of phosphoglyceride and triacylglycerol. Cultured skin fibroblasts from five patients with GKD and from six controls were incubated with [2-3H]glycerol (1 mCi/ml, 1 Ci/ mmol, Amersham) in 199 Earle's medium containing 10% fetal calf serum. Each ml of medium contained 6 pCi of [2-3]glycerol. The fetal calf serum contained 1 mg/dl glycerol. The specific activity of [2-3H]glycerol in the culture medium was 0.5 ,Ci/ mmol. After 18 h of incubation the cells were trypsinized from the culture flasks, suspended in phosphate buffered saline, pH 7.3, and extracted twice with chlorofom::methanol (2::1, v/v). After the solvent was evaporated with nitrogen, the solute was solubilized in 150 p1 chloroform::methanol(2:: 1, v/v) and spotted onto Silica Gel LK50 chromatography plates. The plates were developed in chloroform::methanol::acetic acid::water (50::35::4::2, v/v) (lo), dried, and exposed to iodine vapor. The regions of the silica gel corresponding to iodide stained controls of phosphatidylcholine, phosphatidylserine, phosphatidylinositol, phosphatidylethanolamine, phosphatidylglycerol, and triacylglycerols were scraped from the glass plates and counted in scintillation fluid. [3-3H]glucose (1 mCi/ml, 11.5 Ci/mmol New England Nuclear) was also used to label phosphoglycerides and triacylglycerols in cultured GKD fibroblasts and control fibroblasts. Each ml of culture medium contained 1 pCi of [3-3H] glucose. The specific activity of the [3-3H]glucose in the culture medium was 0.177 mCi/mmol. The rate the cells incorporated [2-3H]glycerol or [3-3H] glucose is expressed as fmol of phosphoglyceride, or triacylglycerols synthesized per mg of cellular protein per min of incubation. The means and SEM were compared by the two-sample unequal variance t test.
EBux of glycerol from cultured jbroblasts GKD fibroblasts
and control fibroblasts were incubated in 199 Earle's medium with 10% fetal calf serum containing [2-3H]glycerol (0.3 pCi/ml of medium). After 6 h of incubation the cells were sequentially washed with fresh medium. Aliquots of each of the washes were counted in scintillation fluid.
RESULTS
GKD fibroblasts incorporated little glycerol into phosphoglycerides and triacylglycerols (Fig. 1) . Most of the glycerol used by GKD fibroblasts was for triacylglycerol biosynthesis, 1.6 (SE 0.3) fmol/mg. min. This limited incorporation is not because GKD fibroblasts failed to transport glycerol across their cell membrane. GKD fibroblasts and control fibroblasts each had the same rate of emux of glycerol. During the 1st min GKD fibroblasts emuxed 17,099 cpm/mg cellular protein (SD 2,490) and control fibroblasts effluxed ! 5,748 cpm/mg cellular protein (SD 3,058).
Nor was the limited incorporation due to a large intracellular glycerol concentration that decreased the specific acticity of [2-3H]glycerol after it entered the GKD fibroblasts. Intracellular glycerol concentration was the same in both GKD fibroblasts and control fibroblasts.
Control fibroblasts incorporated glycerol into phosphoglyceride and triacylglyerol at rates that ranged from 42.7 (SE 8.1)
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The GKD fibroblasts do not utilize glycerol in phosphoglycer- GKD fibroblasts are not dependent on glycerol for glycerol 3-phosphate biosynthesis. They use glucose for glycerol 3-phos- two pathways for the biosynthesis of an initial metabolite, glycerol fphosphate, in phosphoglyceride and triacylglycerol biosynthesis. fmol/mg.min for phosphatidylcholine to 11.3 (SE 2.2) fmol/ mg. min for phosphatidylsenne and phosphatidylinositol.
Overall, GKD fibroblasts utilized glycerol for phosphoglycer-
